Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor.

Yamamoto BJ, Elias PD, Masino JA, Hudson BD, McCoy AT, Anderson ZJ, Varnum MD, Sardinia MF, Wright JW, Harding JW.

J Pharmacol Exp Ther. 2010 Apr;333(1):161-73. doi: 10.1124/jpet.109.161711. Epub 2010 Jan 19. Erratum in: J Pharmacol Exp Ther. 2015 Feb;352(2):379.

2.

A novel angiotensin analog with subnanomolar affinity for angiotensin-converting enzyme.

Krebs LT, Hanesworth JM, Sardinia MF, Speth RC, Wright JW, Harding JW.

J Pharmacol Exp Ther. 2000 Apr;293(1):260-7.

PMID:
10734177
3.

Structural analysis of angiotensin IV receptor (AT4) from selected bovine tissues.

Zhang JH, Hanesworth JM, Sardinia MF, Alt JA, Wright JW, Harding JW.

J Pharmacol Exp Ther. 1999 May;289(2):1075-83.

PMID:
10215690
4.

Characterization and purification of the bovine adrenal angiotensin IV receptor (AT4) using [125I]benzoylphenylalanine-angiotensin IV as a specific photolabel.

Zhang JH, Stobb JW, Hanesworth JM, Sardinia MF, Harding JW.

J Pharmacol Exp Ther. 1998 Oct;287(1):416-24.

PMID:
9765364
5.

Autoradiographic identification of kidney angiotensin IV binding sites and angiotensin IV-induced renal cortical blood flow changes in rats.

Coleman JK, Krebs LT, Hamilton TA, Ong B, Lawrence KA, Sardinia MF, Harding JW, Wright JW.

Peptides. 1998;19(2):269-77.

PMID:
9493859
6.

Characterization of the binding properties and physiological action of divalinal-angiotensin IV, a putative AT4 receptor antagonist.

Krebs LT, Kramár EA, Hanesworth JM, Sardinia MF, Ball AE, Wright JW, Harding JW.

Regul Pept. 1996 Dec 3;67(2):123-30.

PMID:
8958583
7.

AT4 receptor structure-binding relationship: N-terminal-modified angiotensin IV analogues.

Sardinia MF, Hanesworth JM, Krishnan F, Harding JW.

Peptides. 1994;15(8):1399-406.

PMID:
7700843
8.

Central angiotensin IV binding sites: distribution and specificity in guinea pig brain.

Miller-Wing AV, Hanesworth JM, Sardinia MF, Hall KL, Wright JW, Speth RC, Grove KL, Harding JW.

J Pharmacol Exp Ther. 1993 Sep;266(3):1718-26.

PMID:
8371170
9.

AT4 receptor binding characteristics: D-amino acid- and glycine-substituted peptides.

Sardinia MF, Hanesworth JM, Krebs LT, Harding JW.

Peptides. 1993 Sep-Oct;14(5):949-54.

PMID:
8284271
10.

Elucidation of a specific binding site for angiotensin II(3-8), angiotensin IV, in mammalian heart membranes.

Hanesworth JM, Sardinia MF, Krebs LT, Hall KL, Harding JW.

J Pharmacol Exp Ther. 1993 Aug;266(2):1036-42.

PMID:
8355180
11.

Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor.

Swanson GN, Hanesworth JM, Sardinia MF, Coleman JK, Wright JW, Hall KL, Miller-Wing AV, Stobb JW, Cook VI, Harding EC, et al.

Regul Pept. 1992 Aug 13;40(3):409-19.

PMID:
1438983
12.

Identification of an AII(3-8) [AIV] binding site in guinea pig hippocampus.

Harding JW, Cook VI, Miller-Wing AV, Hanesworth JM, Sardinia MF, Hall KL, Stobb JW, Swanson GN, Coleman JK, Wright JW, et al.

Brain Res. 1992 Jun 26;583(1-2):340-3.

PMID:
1504842
13.

Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats.

Wright JW, Roberts KA, Cook VI, Murray CE, Sardinia MF, Harding JW.

Brain Res. 1990 Apr 23;514(1):5-10.

PMID:
2357530
14.

Structure-function analyses of brain angiotensin control of pressor action in rats.

Wright JW, Jensen LL, Roberts KA, Sardinia MF, Harding JW.

Am J Physiol. 1989 Dec;257(6 Pt 2):R1551-7.

PMID:
2604011

Supplemental Content

Loading ...
Support Center